Harbour Investments, Inc. Heron Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$8.35 - $12.6 $9,919 - $14,968	-1,188 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $1,722 - $2,550	-170 Reduced 12.52%	1,188 $13,000
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $2,667 - $3,714	-201 Reduced 12.89%	1,358 $21,000
Q1 2021 Aug 17, 2021	BUY	$14.49 - $20.72 $22,560 - $32,261	1,557 Added 77850.0%	1,559 $25,000
Q1 2021 May 12, 2021	BUY	$14.49 - $20.72 $28 - $41	2 New	2 $0

174

114M

1.99M

65.8K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $211M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.